288 related articles for article (PubMed ID: 34015241)
1. Azithromycin for the Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis: A Randomized Controlled Crossover Trial.
Guler SA; Clarenbach C; Brutsche M; Hostettler K; Brill AK; Schertel A; Geiser TK; Funke-Chambour M
Ann Am Thorac Soc; 2021 Dec; 18(12):2018-2026. PubMed ID: 34015241
[No Abstract] [Full Text] [Related]
2. Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial.
Wu Z; Spencer LG; Banya W; Westoby J; Tudor VA; Rivera-Ortega P; Chaudhuri N; Jakupovic I; Patel B; Thillai M; West A; Wijsenbeek M; Maher TM; Smith JA; Molyneaux PL
Lancet Respir Med; 2024 Apr; 12(4):273-280. PubMed ID: 38237620
[TBL] [Abstract][Full Text] [Related]
3. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.
Birring SS; Wijsenbeek MS; Agrawal S; van den Berg JWK; Stone H; Maher TM; Tutuncu A; Morice AH
Lancet Respir Med; 2017 Oct; 5(10):806-815. PubMed ID: 28923239
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.
Horton MR; Santopietro V; Mathew L; Horton KM; Polito AJ; Liu MC; Danoff SK; Lechtzin N
Ann Intern Med; 2012 Sep; 157(6):398-406. PubMed ID: 22986377
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis.
Lechtzin N; Hilliard ME; Horton MR
Chest; 2013 Jun; 143(6):1745-1749. PubMed ID: 23519393
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Maher TM; Corte TJ; Fischer A; Kreuter M; Lederer DJ; Molina-Molina M; Axmann J; Kirchgaessler KU; Samara K; Gilberg F; Cottin V
Lancet Respir Med; 2020 Feb; 8(2):147-157. PubMed ID: 31578169
[TBL] [Abstract][Full Text] [Related]
7. Phase 2B Study of Inhaled RVT-1601 for Chronic Cough in Idiopathic Pulmonary Fibrosis: A Multicenter, Randomized, Placebo-controlled Study (SCENIC Trial).
Martinez FJ; Wijsenbeek MS; Raghu G; Flaherty KR; Maher TM; Wuyts WA; Kreuter M; Kolb M; Chambers DC; Fogarty C; Mogulkoc N; Tutuncu AS; Richeldi L
Am J Respir Crit Care Med; 2022 May; 205(9):1084-1092. PubMed ID: 35050837
[No Abstract] [Full Text] [Related]
8. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
Wilson AM; Clark AB; Cahn T; Chilvers ER; Fraser W; Hammond M; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett DR; Whyte M;
JAMA; 2020 Dec; 324(22):2282-2291. PubMed ID: 33289822
[TBL] [Abstract][Full Text] [Related]
9. Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial.
Raghu G; van den Blink B; Hamblin MJ; Brown AW; Golden JA; Ho LA; Wijsenbeek MS; Vasakova M; Pesci A; Antin-Ozerkis DE; Meyer KC; Kreuter M; Santin-Janin H; Mulder GJ; Bartholmai B; Gupta R; Richeldi L
JAMA; 2018 Jun; 319(22):2299-2307. PubMed ID: 29800034
[TBL] [Abstract][Full Text] [Related]
10. PAciFy Cough-a multicentre, double-blind, placebo-controlled, crossover trial of morphine sulphate for the treatment of pulmonary Fibrosis Cough.
Wu Z; Banya W; Chaudhuri N; Jakupovic I; Maher TM; Patel B; Spencer LG; Thillai M; West A; Westoby J; Wijsenbeek M; Smith J; Molyneaux PL
Trials; 2022 Mar; 23(1):184. PubMed ID: 35236391
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease.
Brockwell C; Ampikaipakan S; Sexton DW; Price D; Freeman D; Thomas M; Ali M; Wilson AM
Int J Chron Obstruct Pulmon Dis; 2014; 9():715-21. PubMed ID: 25031533
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Azithromycin in Treatment-Resistant Cough: A Randomized, Double-Blind, Placebo-Controlled Trial.
Hodgson D; Anderson J; Reynolds C; Oborne J; Meakin G; Bailey H; Shaw D; Mortimer K; Harrison T
Chest; 2016 Apr; 149(4):1052-60. PubMed ID: 26836927
[TBL] [Abstract][Full Text] [Related]
13. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Behr J; Bendstrup E; Crestani B; Günther A; Olschewski H; Sköld CM; Wells A; Wuyts W; Koschel D; Kreuter M; Wallaert B; Lin CY; Beck J; Albera C
Lancet Respir Med; 2016 Jun; 4(6):445-53. PubMed ID: 27161257
[TBL] [Abstract][Full Text] [Related]
14. Effects of Qizhukangxian granules on idiopathic pulmonary fibrosis: a randomized, double blind, placebo-controlled and multicenter clinical pilot trial.
Guo S; Song Y; Feng J; Liu S; Li Y; Liu M; Wei L; Zhang X; Xie H; Sun Z
J Tradit Chin Med; 2020 Aug; 40(4):674-682. PubMed ID: 32744035
[TBL] [Abstract][Full Text] [Related]
15. Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.
Dutta P; Funston W; Mossop H; Ryan V; Jones R; Forbes R; Sen S; Pearson J; Griffin SM; Smith JA; Ward C; Forrest IA; Simpson AJ
Thorax; 2019 Apr; 74(4):346-353. PubMed ID: 30610155
[TBL] [Abstract][Full Text] [Related]
16. Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher TM; Ford P; Brown KK; Costabel U; Cottin V; Danoff SK; Groenveld I; Helmer E; Jenkins RG; Milner J; Molenberghs G; Penninckx B; Randall MJ; Van Den Blink B; Fieuw A; Vandenrijn C; Rocak S; Seghers I; Shao L; Taneja A; Jentsch G; Watkins TR; Wuyts WA; Kreuter M; Verbruggen N; Prasad N; Wijsenbeek MS;
JAMA; 2023 May; 329(18):1567-1578. PubMed ID: 37159034
[TBL] [Abstract][Full Text] [Related]
17. Modified Maimendong decoction in the treatment of patients with idiopathic pulmonary fibrosis: Study protocol for a randomized controlled trial.
Gan W; Huang Q; Xiao G; Luo Y; Wang J; Zhang C; Liang Y; Huang N; Liao T
Medicine (Baltimore); 2020 Dec; 99(49):e23460. PubMed ID: 33285745
[TBL] [Abstract][Full Text] [Related]
18. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
[TBL] [Abstract][Full Text] [Related]
19. The clinical efficacy of a mixture of ivy leaf extract and coptidis rhizome in patients with idiopathic pulmonary fibrosis.
Lee JH; Jang JH; Park JH; Jung SY; Lee S; Kim SH; Kim JY; Ko J; Choi HE; No TH; Jang HJ
Medicine (Baltimore); 2023 Feb; 102(5):e32786. PubMed ID: 36749235
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
